Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Current Updates on Variants of SARS‐CoV‐ 2: Systematic Review

View through CrossRef
ABSTRACTBackgroundCoronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2, which has become a pandemic. Severe acute respiratory syndrome coronavirus 2 is an enveloped, unsegmented, positive‐sense, single‐stranded RNA virus that belongs to the family Coronaviridae.AimThe objective of this review is to conduct a qualitative analysis of the current updates on epidemiology, evolution, and vaccine variants for SARS‐CoV‐2.MethodThe search strategy was done from the database based on the PRISMA criteria for qualitative analysis of this review. Literature on variants of severe acute respiratory syndrome coronavirus 2, published in English in the last 5 years (2019–2023), were included. From 179 a total of 105 articles were reviewed, searched, and retrieved from the electronic databases PubMed. The search was done using keywords like COVID‐19, SARS‐CoV‐2, variants, mutations, and vaccines, and articles were managed using EndNote X8 software. The scope of view for this review was the course of the pandemic by emerging variants and how man is struggling to overcome this sudden pandemic through vaccines. The narrative skeleton was constructed based on the article's scope of view.ResultFrom the parent severe acute respiratory syndrome coronavirus 2, many variants emerged during the course of this pandemic. They are mainly categorized into two variants: variants of interest and variants of concern based on the impact on public health. The World Health Organization leveled five variants: Alpha (strain B.1.1.7), Beta (strain B.1.351), Gamma (strain P.1), Delta (strain B.1.617.2), and Omicron (B.1.1.529).ConclusionsIt is crucial to stay informed about the latest developments in the understanding of SARS‐CoV‐2 variants, as new variants can emerge and impact the course of the pandemic. Health authorities and researchers continuously have to monitor and study these variants to assess their characteristics, transmissibility, severity, and the effectiveness of vaccines against them. One has to always refer to the latest information from reputable health journals or organizations for the most up‐to‐date and accurate details on COVID‐19 variants.
Title: Current Updates on Variants of SARS‐CoV‐ 2: Systematic Review
Description:
ABSTRACTBackgroundCoronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2, which has become a pandemic.
Severe acute respiratory syndrome coronavirus 2 is an enveloped, unsegmented, positive‐sense, single‐stranded RNA virus that belongs to the family Coronaviridae.
AimThe objective of this review is to conduct a qualitative analysis of the current updates on epidemiology, evolution, and vaccine variants for SARS‐CoV‐2.
MethodThe search strategy was done from the database based on the PRISMA criteria for qualitative analysis of this review.
Literature on variants of severe acute respiratory syndrome coronavirus 2, published in English in the last 5 years (2019–2023), were included.
From 179 a total of 105 articles were reviewed, searched, and retrieved from the electronic databases PubMed.
The search was done using keywords like COVID‐19, SARS‐CoV‐2, variants, mutations, and vaccines, and articles were managed using EndNote X8 software.
The scope of view for this review was the course of the pandemic by emerging variants and how man is struggling to overcome this sudden pandemic through vaccines.
The narrative skeleton was constructed based on the article's scope of view.
ResultFrom the parent severe acute respiratory syndrome coronavirus 2, many variants emerged during the course of this pandemic.
They are mainly categorized into two variants: variants of interest and variants of concern based on the impact on public health.
The World Health Organization leveled five variants: Alpha (strain B.
1.
1.
7), Beta (strain B.
1.
351), Gamma (strain P.
1), Delta (strain B.
1.
617.
2), and Omicron (B.
1.
1.
529).
ConclusionsIt is crucial to stay informed about the latest developments in the understanding of SARS‐CoV‐2 variants, as new variants can emerge and impact the course of the pandemic.
Health authorities and researchers continuously have to monitor and study these variants to assess their characteristics, transmissibility, severity, and the effectiveness of vaccines against them.
One has to always refer to the latest information from reputable health journals or organizations for the most up‐to‐date and accurate details on COVID‐19 variants.

Related Results

Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously evolving, bringing great challenges to the control of the virus. In the...
The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics
The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics
AbstractThe papain‐like protease (PLpro) is an important enzyme for coronavirus polyprotein processing, as well as for virus‐host immune suppression. Previous studies reveal that a...
Pathomorphological changes in lung tissue of guinea pigs in SARS-CoV-2 infection model
Pathomorphological changes in lung tissue of guinea pigs in SARS-CoV-2 infection model
Introduction. The main characteristic of pathogenicity of SARS-CoV-2 virus is its ability to cause death in sensitive laboratory animals. The absence of lethal animal infection mod...
Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method
Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method
Background The rapid evolution of SARS-CoV-2 imposed a huge challenge on disease control. Immune evasion caused by genetic variations of the SARS-CoV-2 spike protein’s ...

Back to Top